![](/-/media/ascrs-website/government-relations/images/cap-1.jpg?h=1125&iar=0&w=1125&hash=684FB6A2B216BA4E1455B16752C17481)
FDA: Ophthalmic drugs and devices
ASCRS advocates to ensure our members and their patients have timely access to innovative drugs and devices and access to compounded medications.
ASCRS advocates to ensure our members and their patients have timely access to innovative drugs and devices and access to compounded medications.
© 2025 ASCRS. All Rights Reserved.